Keratoconjunctivitis sicca associated with potentiated sulphonamides.
Sutton
D J
DJ
Roach
N J
NJ
D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects*; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D004338:Drug Combinations / Q000009:adverse effects; D007637:Keratoconjunctivitis / Q000662:veterinary*; D007638:Keratoconjunctivitis Sicca / Q000139:chemically induced / Q000662:veterinary*; D013411:Sulfadiazine / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*; D000096926:Benzenesulfonamides
D000890:Anti-Infective Agents; D004338:Drug Combinations; D013411:Sulfadiazine; D014295:Trimethoprim; C024873:sulfadiazine, trimethoprim drug combination; D000096926:Benzenesulfonamides